A Prospective Study of Asymptomatic Intracranial Atherosclerotic Stenosis in Neurologically Normal Volunteers in a Japanese Cohort by Ryukichi Matsui et al.
March 2016 | Volume 7 | Article 391
Original research
published: 22 March 2016
doi: 10.3389/fneur.2016.00039
Frontiers in Neurology | www.frontiersin.org
Edited by: 
Pooja Khatri, 
University of Cincinnati, USA
Reviewed by: 
Ronen R. Leker, 
Hadassah University Hospital, Israel 
Nerses Sanossian, 
University of Southern California, USA
*Correspondence:
Shuhei Yamaguchi  
yamagu3n@med.shimane-u.ac.jp
Specialty section: 
This article was submitted to Stroke, 
a section of the journal 
Frontiers in Neurology
Received: 11 January 2016
Accepted: 07 March 2016
Published: 22 March 2016
Citation: 
Matsui R, Nakagawa T, Takayoshi H, 
Onoda K, Oguro H, Nagai A and 
Yamaguchi S (2016) A Prospective 
Study of Asymptomatic Intracranial 
Atherosclerotic Stenosis in 
Neurologically Normal Volunteers in a 
Japanese Cohort. 
Front. Neurol. 7:39. 
doi: 10.3389/fneur.2016.00039
a Prospective study of asymptomatic 
intracranial atherosclerotic stenosis 
in neurologically normal Volunteers 
in a Japanese cohort
Ryukichi Matsui1,2 , Tomonori Nakagawa1 , Hiroyuki Takayoshi1 , Keiichi Onoda1 ,  
Hiroaki Oguro1 , Atsushi Nagai3 and Shuhei Yamaguchi1*
1 Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan, 2 Department of Neurology, Masuda Red 
Cross Hospital, Masuda, Japan, 3 Department of Laboratory Medicine, Faculty of Medicine, Shimane University, 
Izumo, Japan
Atherosclerotic stenosis of major intracranial arteries is a leading cause of ischemic stroke 
in Asia. However, the long-term prognosis of asymptomatic intracranial atherosclerotic 
stenosis (ICAS) in healthy volunteers has not been fully examined. Here, we conducted 
a longitudinal study to examine the prognosis of healthy volunteers with asymptomatic 
ICAS and to determine the risk factors for ICAS, including asymptomatic brain paren-
chymal lesions. We studied 2,807 healthy Japanese volunteers with no history of stroke 
(mean age, 62.0 years). They were followed for a mean interval of 64.5 months. The 
degree of ICAS and the presence of asymptomatic brain lesions were assessed by 
using magnetic resonance imaging. Asymptomatic ICAS was detected in 166 volunteers 
(5.9%) at the initial examination. Moderate and mild stenoses were observed in 1.5 and 
4.4% of patients, respectively. Significant risk factors for ICAS were older age and a his-
tory of hypertension and/or dyslipidemia. During follow-up, ischemic stroke developed 
in 32 volunteers. Seven strokes occurred in the ICAS group, whose stroke incidence 
rate was higher than that in the non-ICAS group (0.78 vs. 0.18% per year). According 
to a Cox regression analysis, asymptomatic ICAS was an independent risk factor for 
future ischemic stroke after adjustment for age. Furthermore, after asymptomatic brain 
lesions were taken into account, ICAS was still a significant risk factor for stroke onset. 
In conclusion, even mild to moderate asymptomatic ICAS was a significant risk factor 
for future stroke, independent of asymptomatic brain lesions, in a healthy Japanese 
population. Mild to moderate ICAS might be a therapeutic target for stroke prevention.
Keywords: asymptomatic brain lesions, asymptomatic intracranial atherosclerotic stenosis, risk factors, 
longitudinal study, magnetic resonance angiography, prognosis
inTrODUcTiOn
Intracranial atherosclerotic stenosis (ICAS) of major arteries represents a common cause of ischemic 
stroke worldwide (1). In patients with ischemic cerebrovascular disease, the presence of ICAS of 
>50% has a predictive value for future recurrent ischemic stroke (2). The occurrence of ICAS is 
associated with advanced age, hypertension, diabetes, and dyslipidemia, and its prevalence increases 
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with a number of risk factors (3). Although the control of risk 
factors can lead to better outcomes in symptomatic ICAS, the 
significance of asymptomatic ICAS remains a matter of debate 
(4). Nahab et  al. (5) reported that the prevalence of coexisting 
ICAS was high in stroke patients, but that the risk of stroke from 
asymptomatic stenosis was low.
Although many studies have investigated the clinical signifi-
cance of ICAS in symptomatic patients with stroke (6, 7), reports 
on the significance of asymptomatic ICAS in healthy volunteers 
over a long follow-up are limited. Takahashi et al. (8) followed 2,924 
Japanese volunteers (mean age, 55 years) without any history of 
stroke for a mean follow-up duration of 63 months. They reported 
that the total incidence of cerebrovascular events in persons with 
ICAS was 1.3% per year. In healthy elderly individuals, on the 
other hand, silent brain infarctions (SBIs) and subcortical white 
matter lesions were considered strong risk factors for the onset 
of subsequent stroke (9, 10). As these asymptomatic ischemic 
lesions are sometimes associated with ICAS, it is important to 
consider the influence of asymptomatic ischemic lesions as well 
as of ICAS on stroke onset. There has been no longitudinal study 
investigating the long-term prognosis of ICAS in combination 
with the role of asymptomatic brain lesions. We performed a 
prospective study to examine whether ICAS was associated with 
subsequent stroke independent of other risk factors, including 
asymptomatic brain lesions, in addition to general vascular risk 
factors in a large number of healthy, elderly Japanese patients.
MaTerials anD MeThODs
subjects
We originally enrolled a total of 3,161 consecutive Japanese 
volunteers who voluntarily underwent a medical examination 
of the brain at the Health Science Center in Shimane between 
December 2000 and December 2010. The inclusion criteria for 
this prospective study were as follows: no history of neurological 
or psychiatric disorders, including stroke, no abnormalities on 
neurological examination, and the provision of informed consent 
to participate in this study. For the medical examination, detailed 
clinical assessments, including medical history, laboratory tests, 
magnetic resonance imaging (MRI) of the brain, and MR angi-
ography (MRA), were performed. The study design, including 
information acquisition from other sources, was approved by the 
institutional ethics committee of Shimane University Hospital.
Diagnosis of icas and silent Brain 
lesions
Magnetic resonance imaging was performed with a 1.5-T scanner 
(Symphony Ultra Gradient, Siemens) and consisted of transverse 
T1- and T2-weighted imaging (T1WI and T2WI, respectively) 
and fluid-attenuated inversion recovery (FLAIR). MRA was also 
performed using a 3-dimensional time-of-flight gradient echo 
technique for evaluating intracranial arteries. Extracranial por-
tions of internal carotid artery (ICA) were not covered in our MRA 
protocol. Vascular stenosis of the main intravascular arteries was 
assessed using the method by Uehara et al. (11): <25% reduction 
of an arterial diameter was graded as normal; 25–49% reduction 
as mild stenosis; 50–74% reduction as moderate stenosis; 75–99% 
reduction as severe stenosis; and no opening as occlusion. The 
middle cerebral artery (MCA), the intracranial portion of the 
ICA, the anterior cerebral artery (ACA), the posterior cerebral 
artery (PCA), and the basilar artery (BA) were evaluated.
Silent brain infarction, periventricular hyperintensity (PVH), 
and the presence of deep and subcortical white matter lesions 
(DSWMLs) were also assessed. SBI was defined as a focally 
hyperintense lesion >3 mm in diameter on T2WI, corresponding 
to a hypointense lesion on T1WI. DSWML and PVH were evalu-
ated separately, because PVH is found adjacent to the ventricles, 
whereas DSWML is found away from them. PVH was graded 
using a scale of 0–4 (12), and we defined grades 3 and 4 as posi-
tive PVH. DSWMLs were graded using a scale of 0–3 according 
to the Fazekas’ grading scale (13), and we defined grades 2 and 
3 as positive DSWML. The radiological assessment was per-
formed by trained neurologists (Tomonori Nakagawa, Hiroyuki 
Takayoshi, and Hiroaki Oguro) on the day of MRA examination, 
and the diagnosis was confirmed within several days after MRA 
examination by neuroradiologists who were blinded to patients’ 
demographic information.
Follow-up of Volunteers
Follow-up information about the participants’ health condi-
tions was obtained yearly by mail or telephone interview, and 
the occurrence and date of medical events were checked. When 
vascular events were suspected, we obtained information regard-
ing the event by questioning physicians in the hospital that the 
patient had attended for details of the events, including imaging 
study results. On the basis of the information obtained from these 
sources, we determined the stroke type, i.e., cerebral infarction, 
transient ischemic attack (TIA), intracerebral hemorrhage, or 
subarachnoid hemorrhage. Because we were interested in the 
occurrence of ischemic events associated with ICAS, we excluded 
volunteers from the analysis who developed intracerebral hemor-
rhage or subarachnoid hemorrhage during the follow-up period 
(n = 10). The final assessment was performed in December 2011.
We could not make any contact with 344 volunteers during 
the follow-up period. As a result, we analyzed data from a total 
of 2,807 volunteers (1,497 men and 1,310 women; mean age, 
62.0 ± 8.5 years), resulting in an 88.8% follow-up rate. The mean 
follow-up period was 64.5 ±  30.1  months, ranging from 10 to 
132 months. We confirmed no difference in the prevalence of ICAS 
between volunteers who were successfully followed and those 
who were lost to follow-up. The selection of the optimal medical 
therapy for vascular risk factors, including antithrombotic agents, 
was at the discretion of the patients’ family physicians.
Background evaluation
Clinical information obtained included age, sex, history of 
hypertension (defined by the use of an antihypertensive agent, 
systolic blood pressure ≥140  mmHg, or diastolic blood pres-
sure ≥90 mmHg), diabetes mellitus (defined as a fasting blood 
glucose level ≥126  mg/dL, HbA1c  ≥  6.5%, or a history of 
treatment for diabetes mellitus), and dyslipidemia (defined as a 
low-density lipoprotein cholesterol level ≥140 mg/dL, triglycer-
ide level ≥150 mg/dL, high-density lipoprotein cholesterol level 
TaBle 2 | Multiple logistic regression analysis of risk factors for 
intracranial atherosclerotic stenosis.
Odds ratio 95% ci P value
Age 1.05 1.03–1.07 <0.001
Hypertension (yes) 1.78 1.28–2.46 <0.001
Diabetes mellitus (yes) 1.41 0.88–2.23 n.s.
Dyslipidemia (yes) 1.53 1.11–2.11 0.009
95% CI, 95% confidence interval.
TaBle 1 | Demographic and magnetic resonance imaging data in 
volunteers with and without intracranial atherosclerotic stenosis.
icas− icas+ P value
Number of volunteers 2,641 166
Age (years) 61.8 ± 8.4 65.6 ± 9.0 <0.001
Sex (M/F, %) 53.1/46.9 56.6/43.4 n.s.
Hypertension (%) 34.4 53.6 <0.001
Diabetes mellitus (%) 9.2 14.5 0.01
Dyslipidemia (%) 46.3 56.6 0.02
Alcohol habit (%) 38.0 40.4 n.s.
Smoking (%) 15.1 12.7 n.s.
SBI (%) 12.7 26.5 0.006
DSWML (grade ≥2) (%) 15.4 31.9 <0.001
PVH (grade ≥3) (%) 3.6 12.7 <0.001
ICAS, intracranial atherosclerotic stenosis; SBI, silent brain infarction; DSWML, deep 
subcortical white matter lesion; PVH, periventricular hyperintensity; n.s., non-significant.
TaBle 3 | Demographic and magnetic resonance imaging data at 
baseline in volunteers with and without ischemic stroke events during 
follow-up.
ischemic stroke (−) ischemic stroke (+) P value
Number of 
volunteers
2,775 32
Age (years) 61.9 ± 8.5 67.3 ± 7.7 <0.001
Sex (M/F, %) 53.3/46.7 59.4/40.6 n.s.
Hypertension (%) 35.2 59.4 0.008
Diabetes mellitus 
(%)
9.4 12.5 n.s.
Dyslipidemia (%) 46.9 50.0 n.s.
Alcohol habit (%) 38.0 50.0 n.s.
Smoking (%) 15.0 9.4 n.s.
SBI (%) 13.3 31.3 0.007
0.069†
DSWML (grade 
≥2) (%)
16.0 46.9 <0.001
0.003†
PVH (grade ≥3) (%) 4.0 9.4 n.s.
ICAS (%) 5.7 21.9 0.002
0.005†
SBI, silent brain infarction; DSWML, deep subcortical white matter lesion; PVH, 
periventricular hyperintensity; ICAS, intracranial atherosclerotic stenosis.
†P value was adjusted for age.
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<40 mg/dL, or a history of treatment with lipid-lowering medica-
tion). A smoker was defined as any subject whose smoking index 
exceeded 200. Regular alcohol consumption was defined as more 
than 58 mL of alcohol consumed per day.
statistical analysis
Group differences were analyzed using the Student’s t-test or 
the chi-squared test. In order to adjust for age and confounding 
factors, a logistic regression analysis or an analysis of covariance 
was performed for the demographic and MRI data. Comparisons 
of cumulative event-free rates for volunteers with or without 
ICAS were done using Kaplan–Meier curves with the log-rank 
test. Cox proportional hazards ratios (HRs) were fitted to ICAS 
data after adjusting for age and other potentially confounding 
factors, including drinking, smoking, hypertension, diabetes, 
dyslipidemia, SBI, DSWML, and PVH. The end point was defined 
as the occurrence of a cerebrovascular event, including cerebral 
infarction and TIA. A level of P < 0.05 was accepted as statisti-
cally significant. Statistical analysis was performed with the SPSS 
software package (version 22, IBM Corp., Armonk, NY, USA).
resUlTs
Asymptomatic ICAS was observed in 166 volunteers (5.9%), of 
whom 42 had moderate and 124 had mild ICAS. In total, stenosis 
was found in 110 MCA sites, 60 ICA sites, 8 ACA sites, 13 PCA 
sites, and 14 BA sites. There was neither severe ICAS nor occlusion 
in this study population. The demographic data and MRI findings 
in the volunteers with and without ICAS at baseline are shown in 
Table 1. The volunteers with ICAS were significantly older than 
those without ICAS. Histories of hypertension, diabetes mellitus, 
and dyslipidemia were all more prevalent in the volunteers with 
ICAS compared to such histories in those without ICAS. In addi-
tion, all asymptomatic brain lesions, including SBI, PVH, and 
DSWML, were also highly prevalent among volunteers with ICAS 
(Table 1). We performed a multiple logistic regression analysis 
to determine the risk factors for ICAS (Table 2). Age, history of 
hypertension, and history of dyslipidemia were independent risk 
factors for ICAS.
During a mean follow-up period of 64.5 months, 32 (1.1%) 
volunteers had a cerebrovascular event: ischemic stroke in 
26 (0.89%) volunteers and TIA in 6 (0.21%) volunteers. Seven 
volunteers developed ischemic stroke from the ICAS group at 
baseline, and the incident rate was 0.78% per year. Three and 
four volunteers developed stroke in the moderate and mild ICAS 
groups, respectively. Their stroke incidence rates were 1.33 and 
0.6% per year, respectively. In the ICAS group, all stroke lesions 
were located in the intracranial arteries with stenosis with the 
exception of one case, in which the lesion was located on the 
opposite side of the stenotic artery. Twenty-five volunteers did 
not show ICAS at baseline, and the stroke incidence rate for this 
group was 0.18% per year. The subject’s characteristics for the 
stroke and non-stroke groups are shown in Table 3. An older age, a 
history of hypertension, and a higher prevalence of asymptomatic 
brain lesions (SBI and DSWML) were associated with ischemic 
stroke events. The prevalence of ICAS at baseline was significantly 
higher in volunteers who developed ischemic stroke events than 
it was in those who did not after adjusting for age.
We performed a Kaplan–Meier analysis with the log-rank test 
for volunteers with or without ICAS. There was a significantly 
higher incidence of ischemic stroke events in volunteers with 
mild or moderate ICAS compared to that in those without ICAS 
TaBle 4 | logistic regression analysis results for the occurrence of 
ischemic stroke events.
Variables hr (95% ci)
Model 1 Model 2 Model 3
ICAS (0 = no, 1 = yes) 3.54§ 
(1.47–8.51)
3.06† 
(1.26–7.46)
2.94† 
(1.20–7.18)
DSWML (grade ≥ 2) (0 = no, 
1 = yes)
2.97‡ 
(1.36–6.48)
2.77† 
(1.25–6.13)
SBI (0 = no, 1 = yes) 1.60 (0.71–3.60)
All analyses were adjusted for age.
HR, hazards ratio; 95% CI, 95% confidence interval; ICAS, intracranial atherosclerotic 
stenosis; DSWML, deep subcortical white matter lesion; SBI, silent brain infarction.
†P < 0.05.
‡P < 0.01.
§P < 0.005.
FigUre 1 | a Kaplan–Meier survival curve showing cumulative rates 
free from ischemic stroke events for volunteers with no intracranial 
atherosclerotic stenosis (icas), mild icas, and moderate icas.
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(P < 0.001, Figure 1). In the Cox regression analysis, volunteers 
with mild or moderate ICAS had significantly higher incidences 
of ischemic stroke events than those without ICAS after adjust-
ing for age [HR, 3.04; 95% confidence interval (CI), 1.17–7.43; 
P = 0.042 for mild ICAS; HR, 6.10; 95% CI, 1.83–20.4, P = 0.003 
for moderate ICAS]. There was no significant difference in stroke 
incidence between volunteers with mild and those with moderate 
ICAS. Furthermore, we assessed the influence of asymptomatic 
brain lesions (i.e., DSWML and SBI) on ICAS contribution to 
stroke events, because the asymptomatic MRI lesions were fre-
quently associated with ischemic stroke events (Table  3). Data 
regarding asymptomatic MRI lesions were incorporated into 
multiple regression models in a stepwise fashion after adjusting 
for age. The following variables were used for each model: the 
presence of ICAS for Model 1, the presence of ICAS and DSWML 
for Model 2, and the presence of ICAS, DSWML, and SBI for 
Model 3. As seen in Table 4, ICAS was still a significant inde-
pendent risk factor for ischemic stroke events after adjusting for 
DSWML and SBI (Models 2 and 3 in Table 4).
DiscUssiOn
Results from the current longitudinal cohort study demon-
strated that even mild to moderate asymptomatic ICAS was an 
independent risk factor for future ischemic stroke in a healthy 
population. Many studies have confirmed that there is a high 
risk of vascular events in patients with symptomatic ICAS who 
had already experienced stroke. In a Chinese multicenter study, 
a higher frequency of recurrent stroke was associated with 
increasing severity of ICAS (14), indicating the importance of 
the degree of intracranial vascular stenosis. Wong and Li (15) 
reported an annual recurrent stroke rate of 17.1% for patients 
with symptomatic ICAS. On the other hand, the prognosis of 
asymptomatic ICAS has not been fully examined, especially 
in healthy volunteers. Kremer et  al. (16) studied 50 Caucasian 
patients with asymptomatic atherosclerotic MCA stenosis 
(MCAS) and concluded that asymptomatic MCAS appeared to 
have a benign long-term prognosis with a low risk of ipsilateral 
stroke. Another study compared the prognosis of symptomatic 
and asymptomatic MCAS and reached a similar conclusion 
(12.5% for symptomatic ICAS and 2.8% for asymptomatic ICAS) 
(17). Furthermore, a recent hospital-based study reported that the 
recurrence rate of cerebrovascular events was 12.3% per year for 
symptomatic ICAS and 0.88% per year for asymptomatic ICAS 
(18). This incidence rate of stroke from asymptomatic ICAS was 
similar to that found in our study (0.78% per year). Even though 
stroke incidence from asymptomatic ICAS is relatively low, our 
study showed that the stroke incidence in the ICAS group was 
significantly higher compared to that in the non-ICAS group 
(0.18% per year). Thus, incidental identification of asymptomatic 
ICAS in healthy volunteers should not be ignored, even when the 
stenosis is mild.
Elderly people with SBI and DSWML have been reported to be 
at a highly increased risk of stroke, which could not be explained 
by other major stroke risk factors (9, 10). Park et al. (19) reported 
that symptomatic ICAS was independently associated with pro-
gressively greater DSWML burden, and the association of ICAS 
with DSWML severity appeared to be stronger than that of the 
relationship of DSWML severity with extracranial atherosclerotic 
stenosis. That study indicated that symptomatic ICAS was associ-
ated with DSWML, but it is not clear how much asymptomatic 
ICAS affects the emergence of asymptomatic brain lesions, such 
as SBI and DSWML. We conducted a logistic regression analysis 
that incorporated asymptomatic brain lesions into the regression 
models, and the results showed that asymptomatic ICAS was still a 
significant predictor for ischemic stroke events. The current study 
demonstrated that asymptomatic ICAS and DSWML indepen-
dently contributed to future stroke occurrence. To the best of our 
knowledge, this is the first study to demonstrate asymptomatic 
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ICAS as an independent risk factor for future stroke, even in 
healthy volunteers, after adjusting for asymptomatic brain lesions, 
which are strong risk factors for ischemic stroke.
The control of risk factors for ICAS is important for preventing 
stroke associated with ICAS lesions, because most risk factors are 
treatable. The current study demonstrated that age, hypertension, 
and dyslipidemia were independent risk factors for asympto-
matic ICAS. Many studies have investigated the risk factors for 
asymptomatic and symptomatic ICAS. Histories of lipid disorder 
and metabolic syndrome were common in patients with severe 
intracranial stenosis in the warfarin vs. aspirin for symptomatic 
intracranial disease (WASID) trial (7). Age and diabetes were 
independently associated with moderate to severe ICAS in the 
Barcelona-AsIA study (20). A long-term longitudinal study with 
medical intervention would be necessary in order to determine 
the optimal strategy for preventing stroke onset in patients with 
asymptomatic ICAS.
The prevalence of asymptomatic ICAS was 5.9% in this 
Japanese cohort. Many studies have confirmed that extracranial 
carotid atherosclerotic stenosis is the most common vascular 
lesion found in Caucasian stroke patients, while intracranial 
atherosclerotic disease is found commonly among stroke patients 
of Asian, African-American, and Hispanic ancestry (21, 22). In 
previous Asian studies using transcranial Doppler imaging, the 
prevalence of asymptomatic intracranial atherosclerosis ranged 
from 6 to 24.5% depending on the age and degree of vascular 
risk in recruited volunteers (3, 11, 23, 24). The discrepancy in 
the prevalence rate among studies might be due to differences in 
the number of risk factors and kind of assessment tools. The low 
prevalence of ICAS in our study may be attributed to the lower 
number of risk factors compared to that in studies for high-risk 
patients.
An optimal medication has not been found for ICAS patients. 
Antithrombotic therapy for intracranial arterial stenosis was 
evaluated in the WASID trial. The authors reported that the risk 
of stroke in the territory of the stenotic artery was the highest in 
patients with severe stenosis (HR, 2.03) (25). In case of asymp-
tomatic ICAS, medical intervention has not been considered 
because the stroke risk is relatively low. However, because the 
long-term prognosis in asymptomatic ICAS patients is worse 
compared to that in non-ICAS volunteers, the stenotic lesions 
may be a treatment target for such medications as cilostazol, 
which was reported to improve ICAS lesions (26).
The limitation of this study is that it was not possible to regu-
late the treatment for vascular lesions and risk factors because 
our brain examination system was only for medical examination, 
and the optimal medical therapy, including antithrombotic 
agents, was at the discretion of the patients’ family physicians. 
The information of adherence to medical treatment and control 
status of risk factors was not available. The possibility exists that 
stroke may have occurred in volunteers under inappropriate 
medical conditions. However, this is unlikely, because volunteers 
underwent the brain examination voluntarily and at their own 
expense. Second, the assessment of vascular stenosis was per-
formed with just one modality (i.e., MRA). Most cohort studies 
used a Doppler device for detecting MCAS, which is inevitably 
limited for surveillance because the detection rate of stenosis 
is dependent on the operator’s skill, and it is difficult to study 
vessels other than the MCA with Doppler imaging. Thus, direct 
comparisons of our study with previous cohort studies are dif-
ficult. Furthermore, it was not clear whether the development 
of stroke was associated with progression of vascular stenosis, 
because the follow-up MRA data were not available. Longitudinal 
investigation of MRA data would be highly valuable to confirm 
the significance of ICAS.
In conclusion, our longitudinal prospective study using MRI 
and MRA demonstrated that even a mild to moderate degree 
of asymptomatic ICAS is a significant independent risk factor 
for future ischemic stroke independent of asymptomatic brain 
lesions in a healthy population. Future studies are needed to 
improve prognosis in volunteers with asymptomatic ICAS.
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